Polygenic Risk Score Effectively Predicts Depression Onset in Alzheimer’s Disease Based on Major Depressive Disorder Risk Variants is a research paper published in Frontiers in Neuroscience (2022). On theSindex it has a DataRank of 0.564. It has been cited 16 times, with 9 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.425
From this paper's citation signal
Citation Network Contribution
0.139
From 7 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 9 citers.
NIA NIH HHS
Grant: R01 AG057522
National Institutes of Health
Grant: 3P30AG012300-06S1
ROLE FOR FIBROBLAST GROWTH FACTOR IN ALZHEIMERS DISEASE
National Institutes of Health
Grant: 5R01AG017917-20
Epidemiologic Study of Neural Reserve and Neurobiology of Aging
National Institutes of Health
Grant: 5P50AG005138-34
Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5P50AG047270-03
Yale Alzheimer Disease Research Center
National Institutes of Health
Grant: 2P30AG008017-21
EDUCATION AND INFORMATION CORE
National Institutes of Health
Grant: 5P30AG062715-02
Wisconsin Alzheimer's Disease Research center
National Institutes of Health
Grant: 3P50AG008702-11A1S1
GENES, AGING, LEARNING AND DEMENTIA
National Institutes of Health
Grant: 5P30AG028383-07
Clinical Core
National Institutes of Health
Grant: 2P30AG019610-11
Education and Information Transfer Core
National Institutes of Health
Grant: 2P50AG005142-31
Metabolic Factors in AD
National Institutes of Health
Grant: 5P50AG016573-09
CORE--NEUROPATHOLOGY CORE
National Institutes of Health
Grant: 2P30AG028716-08
Claude D. Pepper OAIC
National Institutes of Health
Grant: 5P30AG062429-03
UCSD Alzheimer's Disease Research Centers P30
National Institutes of Health
Grant: 2P50AG025688-11
A Proteogenomic Approach to Understanding AD GWAS Results
National Institutes of Health
Grant: 5P30AG049638-03
Wake Forest Alzheimer's Disease Core Center
National Institutes of Health
Grant: 3P30AG062428-02S3
Cleveland Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5R01AG064803-03
Integrative modeling and dynamic prediction of Alzheimer's disease
National Institutes of Health
Grant: 3P30AG010129-28S1
UC Davis Alzheimer's Core Center
National Institutes of Health
Grant: 5P50AG023501-03
DATA MANAGEMENT AND BIOSTATISTICS
National Institutes of Health
Grant: 3U01AG061356-02S1
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets
National Institutes of Health
Grant: 5R01AG057522-03
Deciphering the regulation of gene expression in the etiology of LOAD
National Institutes of Health
Grant: 5P30AG062422-03
New Approaches to Dementia Heterogeneity
National Institutes of Health
Grant: 3P30AG010124-28S1
Alzheimer's Disease Core Center - Neuroimaging Core I
National Institutes of Health
Grant: 1P30AG053760-01
Michigan Alzheimer's Disease Core Center
National Institutes of Health
Grant: 5P50AG047366-03
Stanford Alzheimer's Disease Research Center
National Institutes of Health
Grant: 2RF1AG015819-16
Risk Factors, Pathology, and Clinical Expressions of AD
National Institutes of Health
Grant: 5P30AG035982-05
Administrative Core
National Institutes of Health
Grant: 3RF1AG022018-11S2
Racial Differences in Late-Life Cognitive decline and risk of Alzheimer's Disease
National Institutes of Health
Grant: 1P30AG010161-01
SHORT-TERM STABILITY OF CLINICAL TESTS
National Institutes of Health
Grant: 1P30AG072958-01
Duke/UNC Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5P50AG005133-31
AMYLOID DEPOSTION, VASCULAR DISEASE AND CLINICAL PROGRESSION OF AD
National Institutes of Health
Grant: 7U01AG046152-05
Pathway discovery, validation and compound identification for Alzheimer's disease
National Institutes of Health
Grant: 5P30AG008051-28
Alzheimer's Disease Core Center
National Institutes of Health
Grant: 5P30AG013854-05
CORE--CLINICAL
National Institutes of Health
Grant: 5P50AG005146-20
ALZHEIMERS DISEASE AND ANIMAL MODELS
National Institutes of Health
Grant: 5P50AG005681-19
Role of LRP &its ligand tPA in LTP &aging
National Institutes of Health
Grant: 5U01AG016976-03
ALZHEIMERS DISEASE DATA COORDINATING CENTER
National Institutes of Health
Grant: 5P50AG005136-21
ALZHEIMERS DISEASE RESEARCH CENTER
National Institutes of Health
Grant: 5P30AG062421-03
Massachusetts Alzheimer's Disease Research Center
National Institutes of Health
Grant: 3P30AG013846-23S1
Boston University Alzheimer's Disease Center
National Institutes of Health
Grant: 5P50AG047266-04
University of Florida - Mt. Sinai Medical Center AD Research Center
National Institutes of Health
Grant: 5P30AG010133-08
CORE-- EDUCATION AND INFORMATION TRANSFER
National Institutes of Health
FWCI
2.40
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Using polygenic scores in combination with symptom rating scales to identify attention-deficit/hyperactivity disorder
Additional file 1 of Using polygenic scores in combination with symptom rating scales to identify attention-deficit/hyperactivity disorder
Additional file 2 of Using polygenic scores in combination with symptom rating scales to identify attention-deficit/hyperactivity disorder
Additional file 2 of Using polygenic scores in combination with symptom rating scales to identify attention-deficit/hyperactivity disorder
Additional file 3 of Using polygenic scores in combination with symptom rating scales to identify attention-deficit/hyperactivity disorder
Additional file 3 of Using polygenic scores in combination with symptom rating scales to identify attention-deficit/hyperactivity disorder